Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2300 (LINC02300)

Target
LINC02300
Molecular classification
Long intergenic non-coding RNA, Non-coding RNA, LncRNA
01

Overview

Long intergenic non-protein coding RNA 2300 (LINC02300) is classified as a long intergenic non-coding RNA (lincRNA)—a subclass of long non-coding RNAs (lncRNAs) that do not overlap with protein-coding genes and are typically longer than 200 nucleotides[3][1][5]. lincRNAs are known to play diverse regulatory roles within the cell, including fine-tuning gene expression, modulating chromatin architecture, sequestering specific proteins or RNAs, and sometimes acting as enhancer RNAs, although functional annotation for most lincRNAs (including LINC02300) remains incomplete[5][7][8][9]. There is no established evidence that LINC02300 encodes a protein, acts as a druggable therapeutic target, or is directly implicated in particular human diseases[1][3]. As is typical for most annotated lincRNAs, LINC02300 may contribute to various gene regulatory networks, but its specific biological function is not yet documented in the scientific literature[1][3][5].

Other names
LINC02300
02

Biological functions

Regulation of gene expressionChromatin remodelingTranscriptional regulationPossibly enhancer-like activity
03

Disease associations

Other (No specific disease association is known for LINC02300 as of current knowledge)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2300 (LINC02300).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2300 (LINC02300).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call